Measuring outcome in spasticity rehabilitation;Ergebnismessung in der spastik-rehabilitation

Wiener Klinische Wochenschrift, Supplement

Volumn 113, Issue 4, 2001, Pages 11-15

  Fheodoroff, K ^a   Wissel, J ^a   Entner, T ^a   Freimuller M ^a  

^a Gailtal Klinik Hermagor   (Austria)

Author keywords

Botulinum toxin; Economics; Outcome measures; Rehabilitation; Spasticity; Therapy

Indexed keywords

HEALTH CARE PERSONNEL; HUMAN; MOTOR NEURON DISEASE; MUSCLE LENGTH; MUSCLE TONE; REVIEW; SPASTICITY; TREATMENT OUTCOME; VALIDATION PROCESS; VOLUNTARY MOVEMENT;

ACTIVITIES OF DAILY LIVING; ADULT; BOTULINUM TOXIN TYPE A; CAREGIVERS; CHILD; COST-BENEFIT ANALYSIS; DOUBLE-BLIND METHOD; HUMANS; MUSCLE SPASTICITY; MUSCLE TONUS; MUSCLES; NEUROMUSCULAR AGENTS; OUTCOME ASSESSMENT (HEALTH CARE); PAIN; PATIENT SATISFACTION; PHYSICAL THERAPY MODALITIES; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS; RANGE OF MOTION, ARTICULAR; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TREATMENT OUTCOME;

EID: 0034748899     PISSN: 03005178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Measurement and assessment: What & why?
2. Daten sammeln und auswerten
3. Measuring outcomes in cerebral palsy
4. Interrater reliability of a modified Ashworth scale of muscle spasticity
5. Adult norms for the nine hole peg test of finger dexterity
6. Applying overviews and meta-analyses at the bedside
7. Botulinum toxin type A in the treatment of upper extremity spasticity: A randomized, double-blind, placebo-controlled trial
8. Botulinum Toxin A in the management of spastic gait disorders in children and young adults with cerebral palsy: A randomized double-blind study of "high-dose" versus "low-dose" treatment
9. Clinically relevant designs for rehabilitation research: The idiographic model
10. Toward a methodology for rehabilitation research
11. A la recherche d'une technique de mesure de la spasticite
12. Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy
13. Functional abilities after stroke: Measurement, natural history and prognosis
14. The Barthel ADL index: A standard measure of physical disability?
15. Clinical gait assessment in the neurologically impaired: Reliability and meaningfulness
16. Treatment of dystonia using Botulinum Toxin
17. Safety and tolerance of a single dose of botulinum toxin type a in patients with local spasticity-associated problems: A prospective open multicenter study comprising 204 patients